Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 27, 2015 3:07 PM ET

Company Overview of Austen BioInnovation Institute in Akron

Company Overview

Akron, OH 

United States

Founded in 2009

Key Executives for Austen BioInnovation Institute in Akron

Chief Executive Officer and President
Age: 70
Chief Operating Officer
Age: 64
Compensation as of Fiscal Year 2014.

Austen BioInnovation Institute in Akron Key Developments

ADB International Group, Inc. Announces Partnership with Austen Bioinnovation Institute in Akron to Bring E-QURE BST Wound Healing Device to U.S. Market

ADB International Group Inc. announced a partnership with Austen BioInnovation Institute in Akron for the purpose of bringing ADBI's E-QURE BST(TM), a bioelectrical signal therapy device (the E-QURE BST Device), to the U.S. market. The Institute, which has significant expertise in wound healing, clinical trial development and regulatory operations, will conduct a clinical trial that will include 70 patients in a double-arm, controlled, randomized, multi-center study to assess the safety and efficacy of the E-QURE BST Device in subjects with stage II & III Pressure and Venus Stasis ulcers, as an adjunct to the 'Standard of Care'. The company's E-QURE BST Device currently is marketed in Europe for similar indications. It aims to accelerate healing of hard-to-heal chronic wounds by delivering electrical stimulation to an injury site and thus effectively mimicking the electrical currents of chronic wounds in order to enhance the body's natural healing mechanisms. The company's management selected ABIA's Product Innovation and Commercialization Division to spearhead its pre-market clinical trial program, which is necessary to apply for regulatory approval from the FDA to distribute in the United States. ABIA will prepare on behalf of the company an investigative device exemption application to obtain FDA approval to conduct the clinical trials. The initial trial includes 70 patients in a double-arm, randomized, multi-center study to assess the safety and efficacy of E-QURE's BST Device of which data will be submitted to the U.S. Food and Drug Administration to obtain marketing clearance.

Lorain County Community College District and Austen BioInnovation Institute in Akron Join to Advance Medical Technologies

Lorain County Community College District and the Austen BioInnovation Institute in Akron (ABIA) are leveraging their complementary strengths to build a partnership to accelerate the commercialization of novel medical technologies that can advance economic growth, stimulate job creation, foster talent development, enrich patient care and improve community health in Northeast Ohio. Nationally, the Advanced Manufacturing Partnership (AMP), created as a collaborative led by National Institute of Standards and Technology (NIST), cited the "missing middle" as the gap between research and market, and as a primary barrier of moving new inventions to market and creating jobs.

Similar Private Companies By Industry

Company Name Region
Liquafaction Corporation United States
Attain Services Corp. United States
DST Retirement Solutions, LLC United States
CEP Compression United States
Worldwide Labor Support Of Illinois, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Austen BioInnovation Institute in Akron, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at